Neurogene Inc. · NASDAQ:NGNE

Cvijic Christine Mikail sold 9,600 Neurogene Inc. shares (Form 4)

Traded May 6, 2026 · Filed May 8, 2026

On May 6, 2026, Cvijic Christine Mikail (Director, President and CFO) sold 9,600 Neurogene Inc. shares at an average US$31.26 for US$300K under a trading plan, leaving 93,640 shares. Filed May 8, 2026 (Form 4).

Sold
9,600 shares
Price
US$31.26 average (US$30.07 to US$32.44)
Value
US$300K
Holding after
93,640 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President and CFO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 6, 2026Common StockSale4,800US$30.0798,440Direct
May 6, 2026Common StockSale4,800US$32.4493,640Direct

Source

View original at SEC

Related